Pharmaceutical care for severe and critically ill patients with COVID-19 / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 158-169, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-828558
ABSTRACT
Severe and critically ill patients with coronavirus disease 2019 (COVID-19) were usually with underlying diseases, which led to the problems of complicated drug use, potential drug-drug interactions and medication errors in special patients. Based on ( 6), and -19 , we summarized the experience in the use of antiviral drugs, corticosteroids, vascular active drugs, antibacterial, probiotics, nutrition support schemes in severe and critically ill COVID-19 patients. It is also suggested to focus on medication management for evaluation of drug efficacy and duration of treatment, prevention and treatment of adverse drug reactions, identification of potential drug-drug interactions, individualized medication monitoring based on biosafety protection, and medication administration for special patients.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Critical Illness
/
Adrenal Cortex Hormones
/
Coronavirus Infections
/
Nutritional Support
/
Probiotics
/
Therapeutic Uses
/
Drug Therapy
/
Pandemics
Limits:
Humans
Language:
Chinese
Journal:
Journal of Zhejiang University. Medical sciences
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS